Caribou Biosciences Inc
NASDAQ:CRBU
Caribou Biosciences Inc
NASDAQ:CRBU
Price:
1.97
USD
5.35%
Market Closed
Market Cap:
$184.1m
Cash Flow Statement
Cash Flow Statement
Caribou Biosciences Inc
Caribou Biosciences Inc
Currency: USD
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||
| Net Income |
(34)
|
(38)
|
(50)
|
(63)
|
(67)
|
(73)
|
(85)
|
(91)
|
(99)
|
(108)
|
(111)
|
(95)
|
(102)
|
(115)
|
(123)
|
(148)
|
(149)
|
(148)
|
(164)
|
(157)
|
(148)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
3
|
4
|
4
|
4
|
3
|
4
|
4
|
5
|
4
|
4
|
|
| Stock-Based Compensation |
1
|
1
|
1
|
3
|
3
|
6
|
8
|
10
|
12
|
12
|
12
|
13
|
14
|
15
|
16
|
16
|
17
|
17
|
15
|
14
|
0
|
|
| Other Non-Cash Items |
0
|
(0)
|
7
|
10
|
4
|
6
|
8
|
9
|
11
|
11
|
10
|
7
|
13
|
15
|
14
|
16
|
12
|
12
|
35
|
34
|
34
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
0
|
33
|
29
|
33
|
29
|
(8)
|
(4)
|
(7)
|
(4)
|
(1)
|
9
|
(12)
|
(7)
|
(6)
|
(15)
|
4
|
(5)
|
(6)
|
(8)
|
(7)
|
(0)
|
|
| Cash from Operating Activities |
(33)
N/A
|
(4)
+89%
|
(13)
-252%
|
(19)
-49%
|
(33)
-69%
|
(75)
-129%
|
(80)
-7%
|
(87)
-9%
|
(91)
-4%
|
(97)
-7%
|
(91)
+7%
|
(97)
-7%
|
(93)
+4%
|
(103)
-10%
|
(120)
-17%
|
(124)
-3%
|
(138)
-11%
|
(138)
+0%
|
(133)
+3%
|
(126)
+6%
|
(111)
+12%
|
|
| Investing Cash Flow | ||||||||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(3)
|
(5)
|
(5)
|
(6)
|
(8)
|
(8)
|
(11)
|
(12)
|
(11)
|
(11)
|
(7)
|
(5)
|
(4)
|
(3)
|
(2)
|
(1)
|
|
| Other Items |
7
|
(1)
|
(1)
|
(2)
|
(174)
|
(246)
|
(257)
|
(263)
|
(87)
|
7
|
32
|
(24)
|
(57)
|
(55)
|
(45)
|
46
|
91
|
118
|
119
|
102
|
104
|
|
| Cash from Investing Activities |
6
N/A
|
(1)
N/A
|
(1)
-65%
|
(3)
-171%
|
(176)
-5 703%
|
(248)
-41%
|
(262)
-5%
|
(268)
-2%
|
(93)
+65%
|
(0)
+100%
|
25
N/A
|
(36)
N/A
|
(68)
-92%
|
(66)
+3%
|
(56)
+15%
|
39
N/A
|
87
+121%
|
113
+31%
|
116
+3%
|
100
-14%
|
102
+2%
|
|
| Financing Cash Flow | ||||||||||||||||||||||
| Net Issuance of Common Stock |
2
|
112
|
112
|
434
|
432
|
324
|
324
|
2
|
2
|
3
|
20
|
20
|
154
|
165
|
148
|
147
|
17
|
5
|
5
|
5
|
5
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
(1)
|
(1)
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
135
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
2
N/A
|
111
+6 305%
|
110
-1%
|
433
+292%
|
433
+0%
|
325
-25%
|
324
0%
|
2
-99%
|
2
-14%
|
3
+31%
|
20
+619%
|
154
+673%
|
154
0%
|
165
+7%
|
148
-11%
|
13
-91%
|
17
+30%
|
5
-72%
|
5
-3%
|
5
+1%
|
5
+4%
|
|
| Change in Cash | ||||||||||||||||||||||
| Net Change in Cash |
(25)
N/A
|
107
N/A
|
96
-10%
|
411
+326%
|
225
-45%
|
2
-99%
|
(17)
N/A
|
(353)
-1 931%
|
(182)
+48%
|
(95)
+48%
|
(46)
+52%
|
22
N/A
|
(7)
N/A
|
(3)
+53%
|
(28)
-749%
|
(72)
-154%
|
(35)
+52%
|
(20)
+43%
|
(13)
+37%
|
(21)
-64%
|
(4)
+81%
|
|
| Free Cash Flow | ||||||||||||||||||||||
| Free Cash Flow |
(34)
N/A
|
(4)
+89%
|
(13)
-256%
|
(21)
-53%
|
(35)
-68%
|
(77)
-123%
|
(85)
-10%
|
(93)
-9%
|
(97)
-5%
|
(105)
-8%
|
(98)
+6%
|
(108)
-10%
|
(105)
+3%
|
(114)
-8%
|
(131)
-15%
|
(131)
+0%
|
(143)
-9%
|
(142)
+1%
|
(136)
+5%
|
(128)
+6%
|
(112)
+12%
|
|
Switch to:
Switch to:
See Also
Discover More
